CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 409 filers reported holding CRISPR THERAPEUTICS AG in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,021 | -58.2% | 375 | -48.3% | 0.00% | – |
| Q2 2023 | $40,702 | +24.1% | 725 | 0.0% | 0.00% | – |
| Q1 2023 | $32,792 | +11.3% | 725 | 0.0% | 0.00% | – |
| Q4 2022 | $29,471 | -37.3% | 725 | 0.0% | 0.00% | – |
| Q3 2022 | $47,000 | +6.8% | 725 | 0.0% | 0.00% | – |
| Q2 2022 | $44,000 | +15.8% | 725 | +20.8% | 0.00% | – |
| Q1 2022 | $38,000 | -69.6% | 600 | -63.6% | 0.00% | – |
| Q4 2021 | $125,000 | -3.1% | 1,650 | +43.5% | 0.00% | -100.0% |
| Q3 2021 | $129,000 | +14.2% | 1,150 | +64.3% | 0.00% | – |
| Q2 2021 | $113,000 | +32.9% | 700 | 0.0% | 0.00% | – |
| Q1 2021 | $85,000 | -20.6% | 700 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $107,000 | +81.4% | 700 | 0.0% | 0.00% | – |
| Q3 2020 | $59,000 | +15.7% | 700 | 0.0% | 0.00% | – |
| Q2 2020 | $51,000 | +168.4% | 700 | +55.6% | 0.00% | – |
| Q1 2020 | $19,000 | +216.7% | 450 | +350.0% | 0.00% | – |
| Q4 2019 | $6,000 | +50.0% | 100 | 0.0% | 0.00% | – |
| Q3 2019 | $4,000 | -20.0% | 100 | 0.0% | 0.00% | – |
| Q2 2019 | $5,000 | +25.0% | 100 | 0.0% | 0.00% | – |
| Q1 2019 | $4,000 | +33.3% | 100 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | -25.0% | 100 | 0.0% | 0.00% | – |
| Q3 2018 | $4,000 | -20.0% | 100 | +25.0% | 0.00% | – |
| Q2 2018 | $5,000 | – | 80 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $27,989,046 | 33.20% |
| Gilfoyle Management LLC | 100 | $4,842 | 15.90% |
| NEA Management Company, LLC | 1,587,854 | $89,142,124 | 6.80% |
| ARK Investment Management | 7,338,447 | $411,980,394 | 2.73% |
| Nikko Asset Management Americas, Inc. | 3,533,357 | $198,327,328 | 2.09% |
| Del-Sette Capital Management, LLC | 33,661 | $1,889,729 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Merlin Capital, Inc | 8,802 | $494,144 | 1.67% |
| Green Alpha Advisors, LLC | 34,373 | $1,929,700 | 1.27% |